FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines

被引：3

作者：

Modeliard, Santhi Samy

Serot, Jean-Marie

Mansour, Janette

Achard, Jean-Michel

Fournier, Albert

机构：

[1] CHU Amiens, Serv Nephrol, F-80054 Amiens 1, France

[2] CHU Amiens, Dept Geriatr, F-80054 Amiens 1, France

[3] CHU Limoge, Dept Physiol, Limoges, France

来源：

JOURNAL OF HYPERTENSION | 2006年 / 24卷 / 06期

关键词：

D O I：

10.1097/01.hjh.0000226215.18808.f4

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：1213 / 1215

页数：3

共 12 条

[1] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].

Dahlöf, B ;

Sever, PS ;

Poulter, NR ;

Wedel, H ;

Beevers, DG ;

Caulfield, M ;

Collins, R ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J .

LANCET, 2005, 366 (9489) :895-906

[2] Cerebroprotection mediated by angiotensin II - A hypothesis supported by recent randomized clinical trials [J].

Fournier, A ;

Messerli, FH ;

Achard, JM ;

Fernandez, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (08) :1343-1347

[3]

HACKENTHAL E, 1994, TXB HYPERTENSION, P232

[4] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[5] Blood pressure and cardiovascular disease in the Asia Pacific region [J].

Lawes, CMM ;

Rodgers, A ;

Bennett, DA ;

Parag, V ;

Suh, I ;

Ueshima, H ;

MacMahon, S .

JOURNAL OF HYPERTENSION, 2003, 21 (04) :707-716

[6]

Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8

[7] The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients [J].

Liu, LS ;

Zhang, YQ ;

Liu, GZ ;

Li, W ;

Zhang, XZ ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 2005, 23 (12) :2157-2172

[8] Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol [J].

London, GM ;

Asmar, RG ;

O'Rourke, MF ;

Safar, ME .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) :92-99

[9] Effect of different antihypertensive drug classes on central aortic pressure [J].

Morgan, T ;

Lauri, L ;

Bertram, D ;

Anderson, A .

AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (02) :118-123

[10] Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) [J].

Poulter, NR ;

Wedel, H ;

Dahlöf, B ;

Sever, PS ;

Beevers, DG ;

Caulfield, M ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J ;

Pocock, S .

LANCET, 2005, 366 (9489) :907-913

← 1 2 →